Iftach Seri
CEO & Board Member
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Wavelength Pharmaceuticals
Former names: Chemagis, Perrigo API, Perrigo
Active Pharmaceutical Ingredients
Stealth Mode
by SK Capital Partners on Nov, 2017
Wavelength Pharmaceuticals
Wavelength Pharmaceuticals Overview
Wavelength Pharmaceuticals develops and manufactures active pharmaceutical ingredients and select finished dosage forms.
The company focuses on differentiated products that require sophisticated manufacturing processes. Its solution provides customers with comprehensive technical support and in-depth regulatory support across the entire product lifecycle, from project inception to commercial production.
Wavelength Pharmaceuticals core strengths include complex chemistry, innovative process development, crystalline forms, and particle design. It tailors customized solutions to meet individual customer requirements, including full spectrum API CDMO services from preclinical grams to multi-ton commercial quantities.
The company focuses on differentiated products that require sophisticated manufacturing processes. Its solution provides customers with comprehensive technical support and in-depth regulatory support across the entire product lifecycle, from project inception to commercial production.
Wavelength Pharmaceuticals core strengths include complex chemistry, innovative process development, crystalline forms, and particle design. It tailors customized solutions to meet individual customer requirements, including full spectrum API CDMO services from preclinical grams to multi-ton commercial quantities.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Wavelength Pharmaceuticals Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Sep 14, 2022
www.prnewswire.com
On Demand Pharmaceuticals and Wavelength Pharmaceuticals Awarded BIRD Foundation Grant
#Investment
Aug 17, 2021
www.prnewswire.com
Tikun olam-Cannbit continues to expand its footprint in the pharmaceutical arena
#Partners
Feb 18, 2021
www.businesswire.com
Wavelength Pharmaceuticals Further Strengthens Its Global Supply Chain with Acquisition of Vanamali Organics
undefined
Apr 20, 2020
www.businesswire.com
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients
undefined
Apr 20, 2020
www.contractpharma.com
Wavelength Ups API Production for Essential Respiratory Meds
#Customers, Expand
Companies you might be interested in
Driven by Finder AI
-
NurExone BiologicEV-based Drug Platform to Treat Damage in the Central Nerve System11-50 employees • Funding Stage: Public
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar? -
Hopec PharmaImmunotherapy Treatment for Bladder Cancer1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
Emris PharmaPreventing EGFRi skin toxicities, enhancing patient quality of life & Compliance for Cancer Patients1-10 employees • Funding Stage: Pre-Seed
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
IS
SI
BD
AK
Contact Team
Affiliated Organizations
(null)Web & social links
https://www.wavelengthpharma.com
Locations
Israel
Ramat Hovav, Israel
Shlomo Shmeltzer Road 94, Petah Tikva, Israel
Offices Abroad
Ronda del General Mitre, 126, Barcelona, Spain
1700 Route 23, Wayne, NJ 07470, USA
Photos & videos
(2)No Data, yet.
Sorry, no content found under this section.
Wavelength Pharmaceuticals Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Wavelength Pharmaceuticals Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
M&A
Undisclosed
Dec 2021
Type
Merger
Merged to
SEQENS
Undisclosed
M&A
EXIT
$110M
Nov 2017
Type
Acquisition
Was acquired by
SK Capital Partners
$110M
Private Equity Funding
Non-Equity Funding
Mergers and Acquisitions
M&A
Undisclosed
Feb 2021
Type
Acquisition
Acquired
Vanamali Organics
Undisclosed
M&A
Undisclosed
Feb 2021
Type
Acquisition
Acquired
Vanamali Organics
Undisclosed
Wavelength Pharmaceuticals Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
M&A
Undisclosed
Dec 2021
Type
Merger
Merged to
SEQENS
Undisclosed
M&A
Undisclosed
Feb 2021
Type
Acquisition
Acquired
Vanamali Organics
Undisclosed
M&A
Undisclosed
Feb 2021
Type
Acquisition
Acquired
Vanamali Organics
Undisclosed
M&A
EXIT
$110M
Nov 2017
Type
Acquisition
Was acquired by
SK Capital Partners
$110M
Wavelength Pharmaceuticals News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Sep 14, 2022
www.prnewswire.com
On Demand Pharmaceuticals and Wavelength Pharmaceuticals Awarded BIRD Foundation Grant
#Investment
Aug 17, 2021
www.prnewswire.com
Tikun olam-Cannbit continues to expand its footprint in the pharmaceutical arena
#Partners
Feb 18, 2021
www.businesswire.com
Wavelength Pharmaceuticals Further Strengthens Its Global Supply Chain with Acquisition of Vanamali Organics
undefined
Apr 20, 2020
www.businesswire.com
Wavelength Pharmaceuticals Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19 Patients
undefined
Apr 20, 2020
www.contractpharma.com
Wavelength Ups API Production for Essential Respiratory Meds
#Customers, Expand
Related Content
Wavelength Pharmaceuticals Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
NurExone BiologicEV-based Drug Platform to Treat Damage in the Central Nerve System11-50 employees • Funding Stage: Public
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar? -
Hopec PharmaImmunotherapy Treatment for Bladder Cancer1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
Emris PharmaPreventing EGFRi skin toxicities, enhancing patient quality of life & Compliance for Cancer Patients1-10 employees • Funding Stage: Pre-Seed
shared sectors
Also shared
Are these companies similar?
Wavelength Pharmaceuticals Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,